Ana Galán‐Cobo

<i>STK11/LKB1</i> Mutations and PD-1 Inhibitor Resistance in <i>KRAS</i>-Mutant Lung Adenocarcinoma

Ferdinandos Skoulidis, Michael E. Goldberg, Danielle Greenawalt et al. · Cancer Discovery · 2018 · 1.6K citations · Full text

Medicine, Oncology, Pharmacology +16

LKB1 and KEAP1/NRF2 Pathways Cooperatively Promote Metabolic Reprogramming with Enhanced Glutamine Dependence in <i>KRAS</i> -Mutant Lung Adenocarcinoma

Ana Galán‐Cobo, Piyada Sitthideatphaiboon, Xiao Qu et al. · Cancer Research · 2019 · 274 citations · Full text

Life Sciences, Molecular Biology, Oncology +17

MCT4-dependent lactate secretion suppresses antitumor immunity in LKB1-deficient lung adenocarcinoma

Yu Qian, Ana Galán‐Cobo, Irene Guijarro et al. · Cancer Cell · 2023 · 178 citations · Full text

Medicine, Cancer Biology, Oncology +16

CTLA4 blockade abrogates KEAP1/STK11-related resistance to PD-(L)1 inhibitors

Ferdinandos Skoulidis, Haniel A. Araújo, Minh Truong et al. · Nature · 2024 · 155 citations · Full text

Medicine, Immunology, Oncology +17

<i>STK11</i> /LKB1 Mutations in NSCLC Are Associated with KEAP1/NRF2-Dependent Radiotherapy Resistance Targetable by Glutaminase Inhibition

Piyada Sitthideatphaiboon, Ana Galán‐Cobo, Marcelo V. Negrão et al. · Clinical Cancer Research · 2020 · 115 citations · Full text

Medicine, Molecular Genetics, Oncology +17